PCA
HPTX

Private Capital Advisors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Private Capital Advisors’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-18,001
Closed -$396K – 119
2013
Q2 		$396K Buy
+18,001
New +$394K 0.15% 90

Other funds holding HPTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Private Capital Advisors's HPTX Position: Q3 2013 in Review

Private Capital Advisors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q3 2013, closing a stake of 18,001 shares — an estimated $396K sold.

Private Capital Advisors first reported a position in HPTX in Q2 2013 and held it in 1 quarter. The position peaked at $396K in Q2 2013. 61 funds tracked by Wall St. Rank hold HPTX as of Q3 2013.

  • Private Capital Advisors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • Private Capital Advisors sold 18,001 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $396K.
  • Private Capital Advisors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • Private Capital Advisors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $396K in Q2 2013.
  • 61 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on Private Capital Advisors's 13F filing for Q3 2013, filed 18 Oct 2013.